Donley Matthew Maxwell (CIK 1636642) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-03). Recent activity: Buy AUPH (58,160 shares), Sell AUPH (40,761 shares), Sell AUPH (32,901 shares), Buy AUPH (54,166 shares), Sell AUPH (42,787 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-03 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Operating Officer | Buy | 58,160 | $0 |
| 2026-03-03 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Operating Officer | Sell | 40,761 | $579,214 |
| 2026-02-23 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Operating Officer | Sell | 32,901 | $473,774 |
| 2026-01-05 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Operating Officer | Buy | 54,166 | $0 |
| 2026-01-05 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Operating Officer | Sell | 42,787 | $682,453 |
| 2025-03-04 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Operating Officer | Buy | 82,781 | $0 |
| 2025-03-04 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Operating Officer | Buy | 135,567 | $0 |
| 2025-03-04 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Operating Officer | Sell | 65,902 | $527,216 |
| 2025-03-04 | Aurinia Pharmaceuticals Inc. (AUPH) | Chief Operating Officer | Sell | 58,991 | $467,209 |
Source: SEC Form 4 filings · as of 2026-03-03